resTORbio (TORC) Coverage Initiated at Bank of America
Bank of America started coverage on shares of resTORbio (NASDAQ:TORC) in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $23.00 price target on the stock.
Separately, Evercore ISI assumed coverage on shares of resTORbio in a research note on Tuesday. They set an outperform rating and a $28.00 target price on the stock.
Shares of resTORbio (TORC) opened at $19.65 on Tuesday. resTORbio has a one year low of $15.18 and a one year high of $20.74.
ILLEGAL ACTIVITY WARNING: “resTORbio (TORC) Coverage Initiated at Bank of America” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.dailypolitical.com/2018/02/23/restorbio-torc-coverage-initiated-at-bank-of-america.html.
resTORbio Company Profile
resTORbio, Inc is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. It focuses on the mechanistic target of rapamycin (mTOR) pathway that regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1 (TORC1).
Receive News & Ratings for resTORbio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for resTORbio and related companies with MarketBeat.com's FREE daily email newsletter.